Vimarsana
Biggest News Aggregation in the World

Philipp Mathieu News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Philipp Mathieu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Philipp Mathieu Today - Breaking & Trending Today

Immunovia AB appoints new CEO - Vimarsana News

Immunovia AB appoints new CEO

/PRNewswire/ -- As a next step in focusing on the US market The Board of Directors of Immunovia AB (Nasdaq Stockholm: IMMNOV), (publ) ("Immunovia" or the...

Immunovia AB appoints new CEO | MarketScreener - Vimarsana News

Immunovia AB appoints new CEO | MarketScreener

April 29, 2023, Lund, Sweden   LUND, SWEDEN - As a next step in focusing on the US market The Board of Directors of Immunovia AB , has today decided to appoint Jeff Borcherding, until... | April 29, 2023

Immunovia AB: Immunovia to discuss adoption of IMMray PanCan-d with key opinion leaders on May 3, 2023 - Vimarsana News

Immunovia AB: Immunovia to discuss adoption of IMMray PanCan-d with key opinion leaders on May 3, 2023

LUND, Sweden, April 26, 2023 /PRNewswire/ -- Immunovia (Nasdaq Stockholm: IMMNOV), the diagnostics company that has launched the world's first test dedicated to the early detection of pancreatic

Immunovia to participate in National Pancreas Foundation Webinar on Biomarkers and Liquid Biopsy for Early Detection of - Vimarsana News

Immunovia to participate in National Pancreas Foundation Webinar on Biomarkers and Liquid Biopsy for Early Detection of

LUND, Sweden, April 20, 2023 /PRNewswire/ -- Immunovia (Nasdaq Stockholm: IMMNOV), the diagnostics company...

Immunovia to participate in National Pancreas Foundation Webinar on Biomarkers and Liquid Biopsy for Early Detection of Pancreatic Cancer - Vimarsana News

Immunovia to participate in National Pancreas Foundation Webinar on Biomarkers and Liquid Biopsy for Early Detection of Pancreatic Cancer

/PRNewswire/ -- Immunovia (Nasdaq Stockholm: IMMNOV), the diagnostics company that has launched the world's first test dedicated to the early detection of...